Tolmachev V - Search Results

1

Targeting of HER2-expressing tumors with a site-specifically 99mTc-labeled recombinant affibody molecule, ZHER2:2395, with C-terminally engineered cysteine.

Ahlgren S, Wållberg H, Tran TA, Widström C, Hjertman M, Abrahmsén L, Berndorff D, Dinkelborg LM, Cyr JE, Feldwisch J, Orlova A, Tolmachev V. Ahlgren S, et al. Among authors: tolmachev v. J Nucl Med. 2009 May;50(5):781-9. doi: 10.2967/jnumed.108.056929. Epub 2009 Apr 16. J Nucl Med. 2009. PMID: 19372467 Free article.

2

In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker.

Bergström M, Lu L, Fasth KJ, Wu F, Bergström-Pettermann E, Tolmachev V, Hedberg E, Cheng A, Långström B. Bergström M, et al. Among authors: tolmachev v. J Nucl Med. 1998 Jul;39(7):1273-9. J Nucl Med. 1998. PMID: 9669410 Free article.

3

Closo-dodecaborate(2-) as a linker for iodination of macromolecules. Aspects on conjugation chemistry and biodistribution.

Tolmachev V, Koziorowski J, Sivaev I, Lundqvist H, Carlsson J, Orlova A, Gedda L, Olsson P, Sjöberg S, Sundin A. Tolmachev V, et al. Bioconjug Chem. 1999 May-Jun;10(3):338-45. doi: 10.1021/bc980033s. Bioconjug Chem. 1999. PMID: 10346862

4

114mIn, a candidate for radionuclide therapy: low-energy cyclotron production and labeling of DTPA-D-phe-octreotide.

Tolmachev V, Bernhardt P, Forssell-Aronsson E, Lundqvist H. Tolmachev V, et al. Nucl Med Biol. 2000 Feb;27(2):183-8. doi: 10.1016/s0969-8051(99)00096-7. Nucl Med Biol. 2000. PMID: 10773548

5

Cellular processing of (125)I- and (111)in-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells.

Orlova A, Bruskin A, Sjöström A, Lundqvist H, Gedda L, Tolmachev V. Orlova A, et al. Among authors: tolmachev v. Nucl Med Biol. 2000 Nov;27(8):827-35. doi: 10.1016/s0969-8051(00)00148-7. Nucl Med Biol. 2000. PMID: 11150717

6

Optimized indirect (76)Br-bromination of antibodies using N-succinimidyl para-[76Br]bromobenzoate for radioimmuno PET.

Höglund J, Tolmachev V, Orlova A, Lundqvist H, Sundin A. Höglund J, et al. Among authors: tolmachev v. Nucl Med Biol. 2000 Nov;27(8):837-43. doi: 10.1016/s0969-8051(00)00153-0. Nucl Med Biol. 2000. PMID: 11150718

7

Positron emission tomography of experimental melanoma with.

Mårs U, Tolmachev V, Sundin A. Mårs U, et al. Among authors: tolmachev v. Nucl Med Biol. 2000 Nov;27(8):845-9. doi: 10.1016/s0969-8051(00)00147-5. Nucl Med Biol. 2000. PMID: 11150719

8

110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.

Lubberink M, Tolmachev V, Widström C, Bruskin A, Lundqvist H, Westlin JE. Lubberink M, et al. Among authors: tolmachev v. J Nucl Med. 2002 Oct;43(10):1391-7. J Nucl Med. 2002. PMID: 12368379 Free article.

9

Comparative biodistribution of the radiohalogenated (Br, I and At) antibody A33. Implications for in vivo dosimetry.

Orlova A, Höglund J, Lubberink M, Lebeda O, Gedda L, Lundqvist H, Tolmachev V, Sundin A. Orlova A, et al. Among authors: tolmachev v. Cancer Biother Radiopharm. 2002 Aug;17(4):385-96. doi: 10.1089/108497802760363187. Cancer Biother Radiopharm. 2002. PMID: 12396703

10

Combined effect of gefitinib ('Iressa', ZD1839) and targeted radiotherapy with 211At-EGF.

Sundberg AL, Almqvist Y, Orlova A, Blomquist E, Jensen HJ, Gedda L, Tolmachev V, Carlsson J. Sundberg AL, et al. Among authors: tolmachev v. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1348-56. doi: 10.1007/s00259-003-1308-9. Epub 2003 Aug 21. Eur J Nucl Med Mol Imaging. 2003. PMID: 12937952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters